Total Payments
$3,292
2024 Payments
$59.90
Companies
26
Transactions
59
Medicare Patients
6,195
Medicare Billing
$721,928
Payment Breakdown by Category
Food & Beverage$3,292 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,292 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $300.62 | 4 | $0 (2018) |
| PFIZER INC. | $293.87 | 3 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $250.03 | 5 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $243.71 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $235.74 | 6 | $0 (2021) |
| Celgene Corporation | $197.52 | 3 | $0 (2019) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $181.51 | 3 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $177.45 | 2 | $0 (2023) |
| ABBVIE INC. | $169.89 | 3 | $0 (2024) |
| Biofrontera Inc. | $157.00 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.90 | 2 | ABBVIE INC. ($59.90) |
| 2023 | $258.76 | 3 | E.R. Squibb & Sons, L.L.C. ($177.45) |
| 2022 | $46.00 | 2 | Janssen Biotech, Inc. ($23.97) |
| 2021 | $203.57 | 10 | Amgen Inc. ($56.08) |
| 2020 | $374.73 | 7 | Sun Pharmaceutical Industries Inc. ($228.57) |
| 2019 | $853.17 | 13 | Regeneron Healthcare Solutions, Inc. ($243.71) |
| 2018 | $494.66 | 10 | UCB, Inc. ($130.90) |
| 2017 | $1,001 | 12 | Galderma Laboratories, L.P. ($209.16) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.84 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/24/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| Category: Immunology | ||||||
| 09/23/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $81.31 | General |
| Category: Inflammation & Immunology | ||||||
| 05/03/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $142.45 | General |
| Category: Immunology | ||||||
| 04/26/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Immunology | ||||||
| 02/09/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Immunology | ||||||
| 12/15/2021 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: BioOncology | ||||||
| 10/20/2021 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.11 | General |
| Category: Dermatology | ||||||
| 10/13/2021 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: BioOncology | ||||||
| 08/18/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Inflammation | ||||||
| 06/14/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: IMMUNOLOGY | ||||||
| 04/21/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Immunology | ||||||
| 03/31/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Inflammation | ||||||
| 01/27/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Immunology | ||||||
| 01/20/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Immunology | ||||||
| 11/11/2020 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Immunology | ||||||
| 11/04/2020 | Sun Pharmaceutical Industries Inc. | LEVULAN KERASTICK (Drug), BLU-U | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Dermatology | ||||||
| 10/28/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Immunology | ||||||
| 07/01/2020 | Sun Pharmaceutical Industries Inc. | ODOMZO (Drug), BLU-U, LEVULAN KERASTICK | Food and Beverage | Cash or cash equivalent | $66.00 | General |
| Category: Oncology | ||||||
| 03/04/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $109.99 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2020 | Sun Pharmaceutical Industries Inc. | LEVULAN KERASTICK (Drug), BLU-U, ODOMZO | Food and Beverage | Cash or cash equivalent | $21.82 | General |
| Category: Dermatology | ||||||
| 02/05/2020 | Sun Pharmaceutical Industries Inc. | ODOMZO (Drug) | Food and Beverage | In-kind items and services | $120.75 | General |
| Category: Oncology | ||||||
| 12/05/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,474 | 3,689 | $304,990 | $174,663 |
| 2022 | 19 | 1,778 | 4,400 | $394,665 | $224,478 |
| 2021 | 17 | 1,609 | 4,075 | $324,410 | $183,072 |
| 2020 | 12 | 1,334 | 3,537 | $255,785 | $139,715 |
Total Patients
6,195
Total Services
15,701
Medicare Billing
$721,928
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 429 | 1,047 | $110,005 | $70,882 | 64.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 254 | $36,890 | $25,293 | 68.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 215 | 428 | $40,660 | $21,279 | 52.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 134 | 217 | $23,870 | $13,743 | 57.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 114 | 141 | $19,035 | $11,495 | 60.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 162 | 1,366 | $34,150 | $7,775 | 22.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 70 | 79 | $11,850 | $7,725 | 65.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 33 | $10,325 | $5,087 | 49.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 56 | 56 | $8,120 | $4,676 | 57.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $5,660 | $4,203 | 74.3% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $1,495 | $870.60 | 58.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 19 | $1,425 | $842.46 | 59.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 14 | $1,050 | $693.70 | 66.1% |
| 87101 | Fungal culture (mold or yeast) of skin, hair, or nail | Office | 2023 | 13 | 13 | $455.00 | $98.28 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 494 | 1,145 | $119,195 | $83,336 | 69.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 235 | 467 | $44,365 | $24,134 | 54.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 226 | $32,930 | $22,174 | 67.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 170 | 451 | $32,960 | $15,312 | 46.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 150 | 180 | $24,300 | $15,267 | 62.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 84 | 103 | $16,275 | $9,870 | 60.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 172 | 1,517 | $37,925 | $9,154 | 24.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 20 | 22 | $11,220 | $8,452 | 75.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 36 | 42 | $15,951 | $6,518 | 40.9% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 13 | 14 | $9,275 | $5,659 | 61.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 39 | $7,437 | $5,347 | 71.9% |
About Dr. Daniel Gross, MD
Dr. Daniel Gross, MD is a Dermatology healthcare provider based in Tarzana, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396740056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Gross, MD has received a total of $3,292 in payments from pharmaceutical and medical device companies, with $59.90 received in 2024. These payments were reported across 59 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,292).
As a Medicare-enrolled provider, Gross has provided services to 6,195 Medicare beneficiaries, totaling 15,701 services with total Medicare billing of $721,928. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Procedural Dermatology
- Location Tarzana, CA
- Active Since 06/17/2005
- Last Updated 09/11/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1396740056
Products in Payments
- COSENTYX (Biological) $235.74
- Otezla (Drug) $229.99
- EUCRISA (Drug) $212.56
- ODOMZO (Drug) $186.75
- Sotyktu (Drug) $177.45
- SILIQ (Drug) $156.42
- Cimzia (Drug) $130.90
- EPIDUO FORTE (Drug) $129.46
- ACZONE (Drug) $125.39
- QBREXZA (Drug) $125.00
- DUPIXENT (Biological) $121.88
- LIBTAYO (Biological) $121.83
- AMELUZ (Drug) $119.33
- SKYRIZI (Biological) $109.99
- ATOPIC DERMATITIS - DISEASE (Drug) $107.97
- CIBINQO (Drug) $81.31
- Peripheral Orbital Atherectomy System (Device) $80.83
- DUOBRII (Drug) $78.97
- REMICADE (Biological) $74.47
- SOOLANTRA (Drug) $71.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.